To avoid disaster, the Government has limits for legal and illegal drugs, so ask your doctor if you’re unsure. But it’s not ...

This configuration uses MatthewVance's unbound-docker container to implement encrypted DNS to third party DNS resolvers (eg Cloudflare). This is arguably less privacy-friendly since you're handing ...

And scientists are studying how to create healthy retinal cells from a person's own tissue. Once they grow the cells in a lab, the idea is to surgically replace areas of atrophy with a patch of ...

Geographic atrophy (GA) can be visually confusing ... lived experience may not match up with what they hear from their retina specialist. For instance, your visual acuity according to the eye ...

Our goal is to confirm the safety of our drug candidate to then rapidly move into a Phase II proof-of-concept study, to demonstrate transferrin’s ability to protect retinal cells from atrophy ...

PST-611-CT1 is a first-in-human single ascending dose trial aiming to confirm the favorable safety profile of the drug and validate the maximal dose for the Phase II proof-of-concept study, in six to ...

Retinal layer thinning in Multiple Sclerosis (MS) associates with clinical disability, brain atrophy, and neurodegeneration, functioning as a potential biomarker for disease progression and treatment ...

Methods: To address these issues, this study introduces M3B-Net, a novel multi-modal, multi-branch framework that leverages fundus fluorescence angiography (FFA) images to improve retinal vessel ...

According to Ferrone, two common causes of macular holes in children are laser pointer injury and blunt trauma. Ferrone shared several case examples and their resolution. “It is important to get ...

This important work advances our understanding of factors influencing efficacy assessments and biomarker viability for complement-directed gene therapy against age-related macular degeneration. The ...

A global survey explores the impact of geographic atrophy (GA) on quality of life, revealing similar challenges for individuals ... Safety data from the first cohort of the LIGHTHOUSE study will be ...

Structural OCT findings may predict macular atrophy development in patients with macular neovascularization undergoing anti-VEGF treatment. The presence of reticular pseudodrusen and subretinal ...